A De Novo Novel Mutation of the EDNRB Gene in a Taiwanese Boy with Hirschsprung Disease  by Chen, Wen-Chau et al.
349J Formos Med Assoc | 2006 • Vol 105 • No 4
EDNRB mutation in Hirschsprung disease
Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of ganglion cells in the
nerve plexuses of the lower digestive tract. Although mutations in eight different genes (EDNRB, EDN3, ECE1,
SOX10, RET, GDNF, NTN, SIP1) have been identified in affected individuals, it is now clear that RET and
EDNRB are the primary genes implicated in the etiology of HSCR. All eight genes are involved in the early
development of the enteric nervous system, and most act through two distinct biochemical pathways mediated
by RET and EDNRB. Mutations in RET and EDNRB account for up to 50% and 5% of HSCR cases in the
general population, respectively. Interaction between these two signaling pathways could modify RET
expression and, therefore, HSCR phenotype. Here, we report the case of a 1-year-old Taiwanese boy who
presented with abdominal distension since birth and bilious vomiting after feeding. HSCR (short-segment
type) was diagnosed based on X-ray, lower gastrointestinal series and biopsy findings. Mutation analysis
revealed a heterozygous T>C missense mutation in exon 1 of the EDNRB gene, that substitutes the highly
conserved cysteine-90 residue in the extracellular domain of the G protein-coupled receptor with an arginine
residue (C90R). No RET gene mutation was detected in this patient. [J Formos Med Assoc 2006;105(4):
349–354]
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Hirschsprung disease (HSCR, OMIM 142623),
or aganglionic megacolon, is a congenital disor-
der characterized by the absence of enteric gan-
glia along a variable length of the intestine. The
estimated incidence is approximately 1 in 5000
live births. Molecular genetic analysis has identi-
fied several genes that have a role in the develop-
ment of HSCR; the major susceptibility gene for
this disorder is the RET proto-oncogene.1 Genes
encoding functional ligands of the RET-receptor
complex, such as the glial cell line-derived neu-
rotropic factor (GDNF), neurturin (NTN),2 arte-
min (ARTN), persephin (PSPN), and correspond-
ing members of the GDNF-family receptor _
genes (GFR_-1-4),2 have also been suggested as
putative susceptibility genes associated with
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HSCR. Waardenburg-Shah syndrome is a dis-
order of the embryonic neural crest that combines
the clinical features of Waardenburg syndrome
and HSCR.3 Patients with Waardenburg-Shah
syndrome with megacolon have a homozygous
founder mutation in the G-protein-coupled en-
dothelin-B receptor gene (EDNRB),4 whereas het-
erozygous mutations of EDNRB and endothelin-
3 (EDN3)5 have been identified in individuals
with isolated HSCR. Heterozygous mutations of
SOX10 have been described in patients with
megacolon in Waardenburg-Shah syndrome.6
Mutation of the RET gene accounts for up to
20% of sporadic and 50% of familial cases.7 Mu-
tation of the EDNRB gene accounts for 5–10%
of all HSCR cases.8,9 Short-segment HSCR occurs
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Physical examination did not show any pig-
mentary anomalies or deafness. X-ray examina-
tion showed diffuse enlarged bowel gas with
absent bowel gas in the rectal area. Lower gas-
trointestinal series showed an enlarged cecum,
ascending colon and ileum without focal obstruc-
tion sign. Suction biopsy was performed and
pathology revealed no ganglial neurons in the
rectum and sigmoid colon. Acetylcholine ester-
ase stain was positive. Under the impression of
HSCR (short-segment type), colostomy was ar-
ranged.
PCR and automated DNA sequencing
Genomic DNA was extracted from the peripheral
blood (QIAamp Midi Kit; Qiagen, Valencia, CA,
USA) of the proband and parents after obtain-
ing informed consent. DNA samples were then
subjected to mutation screening by amplifica-
tion of segments of the RET and EDNRB genes
with primers (Tables 1 and 2) synthesized on the
basis of intronic sequences from Genbank.
in about 25% of RET-caused cases and in more
than 95% of EDNRB-related cases.8 Even in fami-
lies with apparent monogenic inheritance, there
is incomplete penetrance of disease-causing
mutations and intra- and interfamily variation
of phenotype severity, suggesting that modify-
ing genetic, stochastic or environmental factors
are involved.
In this report, we describe the genetic analysis
of the RET and EDNRB genes in a Taiwanese boy
with HSCR.
Case Report
The proband was a 1-year-old Taiwanese boy
with HSCR. He presented with abdominal dis-
tension since birth and bilious vomiting after
feeding. The baby was born at full term with a
birth weight of 2665 g. He was the first child of
this family. No other family members had a his-
tory of the same symptoms/signs.
Table 1. Polymerase chain reaction primers used for the amplification of the RET gene from genomic
DNA
Exon Forward (5’ ➔ 3’) Backward (5’ ➔ 3’) Product size (bp) AT (°C)
1 CGGCGCTTACCTCGCTTCAG TGTCCCGTTTGCTCCAGGAC 622 62
2 CAGTTCTTTTCTAGCCCGTG ATGATTCCCGTGTGTCTCCA 671 52
3 GTTTACACCAGCCCTGGAGC GCTCTGTCTGCCCCACAAGA 631 55
4 CTGTGGAGCGGAGGAGGGGA CTAGGACAGACGGCGCAGAC 534 62
5 CTGACAACACACATCTGGTC CAGAGACACAGGAAGTGCTG 481 55
6 CGTGTTTGCACCAGTGTGAG CACCCAGTCTACTCTGTGCT 401 53
7 GTTCCAGGACTTAGGCTGTG AGCCTTGCAGCTGTACTGCT 449 53
8 CTGGCACTGTCTTTGCTGCC CTCACAAGCCCTCTCCCAAG 468 55
9 CTCCTCTCCCATAAGCCATG GAACTGACAGCCCTGGCAAC 391 55
10 CAGAAAGGCACTGTGACCAA CAGGCTGACAAGTTGTTTGG 554 52
11 GTAAATGGCAGTACCCATGC CACAGCGCCCTATGGAAATG 592 52
12 GCAGAGACAGGCAGCGTTGC CTCGCTCTGCTTCTCTAGGC 458 55
13 CTCTCTGTCTGAACTTGGGC CAGTAGGGAAAGGGAGAAAG 312 52
14 CAGAGCTGCAGCAGTGCTGC CATGCCATGGCAGGGGCATG 508 52
15 CTGCCATGTCACACCCTGAC GTCAGTATGCTGCCAGGGAG 540 57
16 CAGGAGTGTCTACAGCACTC CATTGCAGAGGGCTAGCACT 340 53
17 CGACAGGGTCAGCAGGTGCT CTGGTTTCTCCTGGGGCTGC 341 58
18 CTTTGGAGTTGGAGACAGAG CATGACTCTCTCTCTCTGCA 361 50
19 CTGGTCTCTTGGAGAGGTCA GGTTCAGAGCAGACTTTGGT 411 50
20 CACAGAAACCACGAGTTTGG CTGCTAGGAGGGAAAATCAC 470 50
AT = annealing temperature.
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For polymerase chain reaction (PCR) amplifi-
cation, approximately 200 ng of genomic DNA,
12.8 pmol of each primer, 10 μmol dNTP and
1.25 U of Taq (Qiagen) were used in a total vol-
ume of 50 μL. The amplification conditions were
94°C for 5 minutes, followed by 40 cycles of 94°C
for 45 seconds, annealing temperature for 45
seconds and 72°C for 45 seconds, and extension
at 72°C for 10 minutes. PCR products were puri-
fied by QIAquick columns (Qiagen) and sequenced
with both forward and backward primers (377
ABI Advanced Biotechnologies, Columbia, MD,
USA).
Automated DNA sequencing of the EDNRB
gene revealed a heterozygous T to C transition of
codon 90 in exon 1 (Figure), which predicted a
substitution of cysteine by arginine (C90R). This
mutation was confirmed with backward primer
for exon 1. Neither of the parents had this mu-
tation. The mutation created a new restriction en-
zyme site (AciI). The mutation was absent in 100
normal unrelated Taiwanese controls by restric-
tion fragment analysis, indicating that it was not a
polymorphism. No mutation was detected in the
RET gene of this patient.
Discussion
HSCR is a frequent neurocristopathy10 character-
ized by the absence of submucosal and myenteric
plexus in a variable length of the gastrointestinal
tract. In the vast majority of cases (80%), the agan-
glionic tract involves the rectum and the sigmoid
colon only (short-segment HSCR), while in 20%
of cases, it extends towards the proximal end of
the colon.11 Although 80% of cases are sporadic,
pedigree and segregation analyses suggested the
involvement of one or several dominant genes
with low penetrance in HSCR.12 A major HSCR
gene has been mapped to chromosome 10q11.2,
and the disease has been ascribed to mutations in
the RET proto-oncogene,1,13–16 which encodes a re-
ceptor tyrosine kinase. However, the lack of geno-
type–phenotype correlations, the low penetrance
and the sex-dependent effect of RET mutations
supported the existence of one or more modifier
gene(s) in familial HSCR.7,17 Puffenberger et al
reported evidence that HSCR type 2 (HSCR2;
OMIM 600155), an apparently multigenic dis-
order, is due to mutations in EDNRB.4
Endothelin (EDN) is a potent vasoactive pep-
tide, which can induce a wide range of cellular
and physiologic responses.18 In mammalian cells,
there are at least two EDN receptor subtypes,
EDNRA and EDNRB,19 both of which belong to
the superfamily of rhodopsin-like G-protein-
coupled receptors (GPCRs)20 that contain seven
Table 2. PCR primers used for the amplification of the EDNRB gene from genomic DNA
Exon Forward (5’ ➔ 3’) Backward (5’ ➔ 3’) Product size (bp) AT (°C)
1 CTCTGCTTGTCTCTAGGCTC GATTCAGTAGGTCTGGGGTG 881 55
2,3 GTGATACAATTCAGAGGGCA CACTGAGATCAAGGGGATTC 734 50
4 CAGTAAGTGTGGCCTGAAAG GTGAAGTGGAACCGAAGTGA 562 50
5 GATCTAGGGAGAATCAGAAC GAAGTACTGAAGCTGGCTGA 643 50
6 GCACAGAAGCTACAATGACT CTACCAAAAACAGGGAACAG 530 50
7 CAAAGAAAGTCAGAACCCTG TCCATGCCGTAAACAGCTCA 407 50
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transmembrane domains. The extracellular and
transmembrane domains of GPCRs are involved
in ligand binding, whereas the intracellular do-
mains are involved in G protein coupling and
subsequent effector regulation. To determine
when EDNRB signaling is required during em-
bryogenesis, Shin et al determined that Ednrb is
required during a restricted period of neural crest
development between embryonic days 10 and
12.5.21 They concluded that EDNRB is required for
the migration of both melanoblasts and enteric
neuroblasts.
Arai et al demonstrated that the human genome
contains a single copy of the EDNRB gene,22 which
spans 24 kb and comprises 7 exons and 6 introns
that encode a 442 amino acid protein expressed in
brain, kidney, lung, heart and endothelial cells.23
Inagaki et al showed that this protein is also ex-
pressed in the human colon, particularly in the
myenteric plexus, mucosal layer, ganglion and
blood vessels of the submucosa.24 Recently, muta-
tions in the EDNRB gene have been identified in
HSCR patients,8 including deletion/insertion
mutations,25,26 non-sense mutations,26–28 splicing
mutations29 and several missense mutations (Table
3).4,5,9,25,30–35 The mutation was dosage sensitive
in that homozygotes and heterozygotes had a
74% and a 21% risk, respectively, of developing
HSCR.4 Other analyses of patients in the extended
Mennonite pedigree showed that HSCR is a
multigenic disorder. For all clinical forms of HSCR,
there is a greater incidence of megacolon in males
than in females, and the same is true for the spe-
cific EDNRB mutation.12
The C90R mutation seems to be significant in
the pathogenesis of HSCR for several reasons: (1)
it was absent in 100 normal controls, making the
hypothesis of a coincidental polymorphism very
unlikely; (2) it led to substitution of a hydrophilic
amino acid with a polar side chain (cysteine) by
Table 3. Endothelin-B receptor gene mutations in Hirschsprung disease (HSCR)/Waardenburg
syndrome (WS)
Mutation Location Phenotype (segment length) Genotype Reference #
169 G>A G57S EC HSCR (S) Heterozygous 30
268 T>C C90R EC HSCR Heterozygous Present case
325 T>C C109R TM I HSCR (S) Heterozygous 31
548 C>G A183G TM III HSCR/WS Homozygous 29
556 G>A G186R TM III HSCR (L)/WS Homozygous 33
601 C>T R201X IL II ABCD syndrome Homozygous 28
678 G>T W226C TM IV HSCR (S&L) Heterozygous 08
707 C>T R253X EL II HSCR (L)/WS Heterozygous 26
801+2 T>C Splicing mutation EL II HSCR (S) Heterozygous 28
824 G>A W275X TM V HSCR (S) Heterozygous 25
828 G>T W276C TM V HSCR (L&S) Heterozygous/homozygous 03
874 T>C F292L TM V HSCR (L)/WS Heterozygous 34
878insT Y293L (PTC+ 6 aa) TM V HSCR (S) Heterozygous 25
914 G>A S305N IL III HSCR (S) Heterozygous 24
928 G>A A310T IL III HSCR (S) Heterozygous 32
955 C>T R319W IL III HSCR (S) Heterozygous 30
1122 G>A M374I TM VII HSCR Heterozygous 04
1132delA N378I (PTC+ 12 aa) TM VII HSCR (S) Heterozygous 24
1148 C>T P383L TM VII HSCR (S) Heterozygous 30
1170 C>A S390R C HSCR (L) Heterozygous 31
ABCD = albinism, black lock, cell migration disorder of the neurocytes of the gut, and deafness; C = carboxyl-terminal region and
adjacent to TM7; EC = extracellular domain; EL = extracellular loop; IL = intracellular loop; L = long-segment; PTC = premature termination
of codon; S = short-segment; TM = transmembrane domain.
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a basic hydrophilic amino acid (arginine); (3)
this region is highly conserved between species,
which probably indicates an important functional
role in EDNRB signaling. The C90R mutation
may change ligand binding. Functional analysis of
the C90R protein will be necessary to determine
the effect of the mutation on the function of the
EDNRB protein.
In conclusion, the detection of a de novo novel
mutation (C90R) of the EDNRB gene in our pa-
tient suggests that dysfunction of the endothelin-
B receptor has a role in the etiology of some cases
of HSCR, especially short-segment HSCR.
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